Search Results - "Ozkaynak, M. Fevzi"

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma by Yu, Alice L, Gilman, Andrew L, Ozkaynak, M. Fevzi, London, Wendy B, Kreissman, Susan G, Chen, Helen X, Smith, Malcolm, Anderson, Barry, Villablanca, Judith G, Matthay, Katherine K, Shimada, Hiro, Grupp, Stephan A, Seeger, Robert, Reynolds, C. Patrick, Buxton, Allen, Reisfeld, Ralph A, Gillies, Steven D, Cohn, Susan L, Maris, John M, Sondel, Paul M

“…This study evaluated whether the addition of a monoclonal antibody against the tumor-associated disialoganglioside GD2, in combination with GM-CSF and…”
Get full text

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group by Erbe, Amy K, Wang, Wei, Carmichael, Lakeesha, Kim, KyungMann, Mendonça, Eneida A, Song, Yiqiang, Hess, Dustin, Reville, Patrick K, London, Wendy B, Naranjo, Arlene, Hank, Jacquelyn A, Diccianni, Mitchell B, Reisfeld, Ralph A, Gillies, Stephen D, Matthay, Katherine K, Cohn, Susan L, Hogarty, Michael D, Maris, John M, Park, Julie R, Ozkaynak, M Fevzi, Gilman, Andrew L, Yu, Alice L, Sondel, Paul M

“…In 2010, a Children's Oncology Group (COG) phase III randomized trial for patients with high-risk neuroblastoma (ANBL0032) demonstrated improved event-free…”
Get full text

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931 by Ozkaynak, M Fevzi, Gilman, Andrew L, London, Wendy B, Naranjo, Arlene, Diccianni, Mitchell B, Tenney, Sheena C, Smith, Malcolm, Messer, Karen S, Seeger, Robert, Reynolds, C Patrick, Smith, L Mary, Shulkin, Barry L, Parisi, Marguerite, Maris, John M, Park, Julie R, Sondel, Paul M, Yu, Alice L

“…A phase 3 randomized study (COG ANBL0032) demonstrated significantly improved outcome by adding immunotherapy with ch14.18 antibody to isotretinoin as…”
Get full text

Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group by Gilman, Andrew L, Ozkaynak, M Fevzi, Matthay, Katherine K, Krailo, Mark, Yu, Alice L, Gan, Jacek, Sternberg, Adam, Hank, Jacquelyn A, Seeger, Robert, Reaman, Gregory H, Sondel, Paul M

“…Recurrence of high-risk neuroblastoma is common despite multimodality therapy. ch14.18, a chimeric human/murine anti-G(D2) antibody, lyses neuroblastoma cells…”
Get full text

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931 by Ozkaynak, M Fevzi, Gilman, Andrew L, London, Wendy B, Naranjo, Arlene, Diccianni, Mitchell B, Tenney, Sheena C, Smith, Malcolm, Messer, Karen S, Seeger, Robert, Reynolds, C Patrick, Smith, L Mary, Shulkin, Barry L, Parisi, Marguerite, Maris, John M, Park, Julie R, Sondel, Paul M, Yu, Alice L

“…[This corrects the article DOI: 10.3389/fimmu.2018.01355.]…”
Get full text

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032 by Yu, Alice L, Gilman, Andrew L, Ozkaynak, M Fevzi, Naranjo, Arlene, Diccianni, Mitchell B, Gan, Jacek, Hank, Jacquelyn A, Batova, Ayse, London, Wendy B, Tenney, Sheena C, Smith, Malcolm, Shulkin, Barry L, Parisi, Marguerite, Matthay, Katherine K, Cohn, Susan L, Maris, John M, Bagatell, Rochelle, Park, Julie R, Sondel, Paul M

“…Previously our randomized phase III trial demonstrated that immunotherapy including dinutuximab, a chimeric anti-GD2 mAb, GM-CSF, and IL2 improved survival for…”
Get full text

Phase I Study of Chimeric Human/Murine Anti–Ganglioside GD2 Monoclonal Antibody (ch14.18) With Granulocyte-Macrophage Colony-Stimulating Factor in Children With Neuroblastoma Immediately After Hematopoietic Stem-Cell Transplantation: A Children’s Cancer Group Study by OZKAYNAK, M. Fevzi, SONDEL, Paul M, KRAILO, Mark D, GAN, Jacek, JAVORSKY, Brad, REISFELD, Ralph A, MATTHAY, Katherine K, REAMAN, Gregory H, SEEGER, Robert C

Get full text

The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia by Carr, Emily, Jayabose, Somasundaram, Stringel, Gustavo, Slim, Michel, Ozkaynak, M. Fevzi, Tugal, Oya, Sandoval, Claudio

“…Background Central venous lines are placed in children with acute lymphoblastic leukemia at diagnosis, despite significant cytopenias, to facilitate the…”
Get full text

Expression of neuroblastoma‐related genes in bone marrow at end of high‐risk neuroblastoma therapy by Asgharzadeh, Shahab, Marachelian, Araz, Villablanca, Judith G., Liu, Wei Yao, Kennedy, Rebekah, Sposto, Richard, Naranjo, Arlene, Tenney, Sheena, Yu, Alice L., Ozkaynak, M. Fevzi, Sondel, Paul M., Park, Julie R., Seeger, Robert C.

“…Background Minimal disease quantification may predict event‐free survival (EFS) and overall survival (OS). Methods We evaluated mRNA expression of five…”
Get full text

Phase I Study of ch 14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue : A Report From the Children's Oncology Group by GILMAN, Andrew L, FEVZI OZKAYNAK, M, SONDEL, Paul M, MATTHAY, Katherine K, KRAILO, Mark, YU, Alice L, GAN, Jacek, STERNBERG, Adam, HANK, Jacquelyn A, SEEGER, Robert, REAMAN, Gregory H

Get full text

The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia by Hochberg, Jessica, Zahler, Stacey, Geyer, Mark B., Chen, Nan, Krajewski, Jennifer, Harrison, Lauren, Militano, Olga, Ozkaynak, M. Fevzi, Cheerva, Alexandra C., Talano, Julie, Moore, Theodore B., Gillio, Alfred P., Walters, Mark C., Baxter-Lowe, Lee Ann, Hamby, Carl, Cairo, Mitchell S.

“…Acute leukemias in children with CR3, refractory relapse, or induction failure (IF) have a poor prognosis. Clofarabine has single agent activity in relapsed…”
Get full text

Infections Due to Nontuberculous Mycobacteria in Children with Leukemia by Levendoglu-Tugal, Oya, Munoz, Jose, Brudnicki, Adele, Fevzi Ozkaynak, M., Sandoval, Claudio, Jayabose, Somasundaram

“…We reviewed the spectrum of infections due to nontuberculous mycobacteria (NTM) in children with leukemia. Three children acquired such infections. One patient…”
Get full text

Urinary Tract Infections in Pediatric Oncology Patients with Fever and Neutropenia by Sandoval, Claudio, Sinaki, Banafsheh, Weiss, Robert, Munoz, Jose, Ozkaynak, M. Fevzi, Tugal, Oya, Jayabose, Somasundaram

“…The relevancy of the urinary tract as a source of infection during febrile neutropenia is not known. The authors sought to determine the frequency of urinary…”
Get full text

Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection method by MAYER, S. P, GIAMELLI, J, SANDOVAL, C, ROACH, A. S, FEVZI OZKAYNAK, M, TUGAL, O, ROVERA, G, JAYABOSE, S

“…PCR-based detection of minimal residual disease (MRD) in children with precursor B cell acute lymphoblastic leukemia (pre-B ALL) by amplification of…”
Get full text

The Usefulness of Preoperative Screening for Bleeding Disorders by Sandoval, Claudio, Garcia, Claudia, Visintainer, Paul, Ozkaynak, M. Fevzi, Jayabose, Somasundaram

“…The results of this retrospective study show that preoperative screening with prothrombin time and activated partial thromboplastin is useful in identifying…”
Get full text

DNA damage response as a biomarker in treatment of leukemias by Halicka, H. Dorota, Ozkaynak, Fevzi, Levendoglu-Tugal, Oya, Sandoval, Claudio, Seiter, Karen, Kajstura, Malgorzata, Traganos, Frank, Jayabose, Somasunadaram, Darzynkiewicz, Zbigniew

“…Early assessment of cancer response to the treatment is of great importance in clinical oncology. Most antitumor drugs, among them DNA topoisomerase (topo)…”
Get full text

Untreated head and neck neuroblastoma by Bjornard, Kari, Jayabose, Somasundaram, Ozkaynak, M. Fevzi, Tugal, Oya, Sandoval, Claudio, McBride, Whitney

Get full text

Clinical and laboratory features of 178 children with recurrent epistaxis by SANDOVAL, Claudio, DONG, Stella, VISINTAINER, Paul, OZKAYNAK, M. Fevzi, JAYABOSE, Somasundaram

“…To determine the clinical and laboratory features of 178 children referred for the evaluation of recurrent epistaxis to an outpatient hematology clinic in a…”
Get full text

GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome by Pine, Sharon R., Guo, Qianxu, Yin, Changhong, Jayabose, Somasundaram, Levendoglu-Tugal, Oya, Ozkaynak, M. Fevzi, Sandoval, Claudio

“…Acquired mutations in exon 2 of the GATA1 gene are detected in most Down syndrome (DS) patients with transient leukemia (TL) and acute megakaryoblastic…”
Get full text

Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura by Sandoval, Claudio, Visintainer, Paul, Ozkaynak, M. Fevzi, Tugal, Oya, Jayabose, Somasundaram

“…Background To determine the clinical features and treatment outcomes of infants with immune thrombocytopenic purpura (ITP). Methods Retrospective analysis of…”
Get full text